MYRNA R ROSENFELD, MD
Neurology in Philadelphia, PA

License number
Pennsylvania MD419661
Category
Neurology
Type
Neurology
Address
Address
3400 Spruce St 2 BUILDING RAVDIN, Philadelphia, PA 19104
Phone
(215) 662-3606

Personal information

See more information about MYRNA R ROSENFELD at radaris.com
Name
Address
Phone
Myrna Rosenfeld
Philadelphia, PA
(215) 413-3890
Myrna D Rosenfeld, age 71
250 Quince St, Philadelphia, PA 19107
(215) 413-3890
Myrna Rosenfeld
34 Walnut Ln, Philadelphia, PA 19144
(215) 746-4707

Professional information

Myrna R Rosenfeld Photo 1

Dr. Myrna R Rosenfeld, Philadelphia PA - MD (Doctor of Medicine)

Specialties:
Neurology, Neuropsychiatry (Neurology)
Address:
3400 Spruce St, Philadelphia 19104
(215) 662-3606 (Phone)
Certifications:
Neurology, 1990
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
3400 Spruce St, Philadelphia 19104
Hospital of the University of Pennsylvania
3400 Spruce St, Philadelphia 19104
Education:
Medical School
Albert Einstein College Of Medicine Of Yeshiva University
Graduated: 1980
Mc Gaw Mc/Northwestern University
University Hospital Of Cleveland


Myrna Rachel Rosenfeld Photo 2

Myrna Rachel Rosenfeld, Philadelphia PA

Specialties:
Neurology
Work:
UPHS-Anesthesiology-Intensive
3400 Spruce St, Philadelphia, PA 19175
Education:
Northwestern University (1985)


Myrna Rosenfeld Photo 3

Methods For Diagnosis Of Encephalitis

US Patent:
7972796, Jul 5, 2011
Filed:
Nov 24, 2008
Appl. No.:
12/277252
Inventors:
Josep Dalmau - Philadelphia PA, US
Myrna Rosenfeld - Philadelphia PA, US
David R. Lynch - Bleubell PA, US
Assignee:
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
This invention provides methods of diagnosing or determining a cause of an autoimmune encephalitis or an epilepsy in a subject and of diagnosing a tumor in a subject, comprising the step of testing a biological sample of the subject for an antibody to an NR1 subunit of the NMDA receptor. This invention further provides methods of treating an autoimmune encephalitis or an epilepsy, comprising the steps of detecting an antibody to an NR1 subunit of the NMDA receptor and treating a tumor associated with the disease.